CAD 0.07
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 5.67 Million CAD | 67.23% |
2022 | 2.36 Million CAD | -64.82% |
2021 | 9.57 Million CAD | 377.57% |
2020 | -3.82 Million CAD | -5.46% |
2019 | -5.44 Million CAD | 69.96% |
2018 | -2.08 Million CAD | -96181.35% |
2017 | -11.4 Thousand CAD | 57.06% |
2016 | -26.55 Thousand CAD | 81.7% |
2015 | -541.62 Thousand CAD | 80.45% |
2014 | -742.27 Thousand CAD | -419.97% |
2013 | -660.57 Thousand CAD | -39.94% |
2012 | -1.49 Million CAD | 92.64% |
2011 | -1.38 Million CAD | -216.59% |
2010 | 1.18 Million CAD | -82.3% |
2009 | 6.72 Million CAD | 1187.53% |
2008 | -618.01 Thousand CAD | 42.24% |
2007 | -1.06 Million CAD | -960.79% |
2006 | -100.86 Thousand CAD | 74.22% |
2005 | -354.17 Thousand CAD | -173.86% |
2004 | -142.88 Thousand CAD | -81.47% |
2003 | -78.73 Thousand CAD | -18.67% |
2002 | -66.35 Thousand CAD | -25.07% |
2001 | -53.04 Thousand CAD | 22.33% |
2000 | -68.3 Thousand CAD | 20.4% |
1999 | -85.8 Thousand CAD | -58.54% |
1998 | -54.12 Thousand CAD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -1.65 Million CAD | 1812.34% |
2024 Q2 | -1.07 Million CAD | -32.43% |
2023 Q2 | 1.01 Million CAD | -22.98% |
2023 Q4 | -3.14 Million CAD | -168.83% |
2023 Q3 | 4.56 Million CAD | 351.19% |
2023 FY | - CAD | -260.6% |
2023 Q1 | 1.31 Million CAD | 226.1% |
2022 Q1 | -2.6 Million CAD | -197.17% |
2022 Q3 | 6.89 Million CAD | 10713.85% |
2022 Q4 | -1.04 Million CAD | -115.1% |
2022 FY | - CAD | -64.82% |
2022 Q2 | -65 Thousand CAD | 97.51% |
2021 Q1 | 4.57 Million CAD | 2331.91% |
2021 Q4 | 2.68 Million CAD | 147.47% |
2021 FY | - CAD | 377.57% |
2021 Q3 | 1.08 Million CAD | -17.3% |
2021 Q2 | 1.31 Million CAD | -71.3% |
2020 Q3 | -175 Thousand CAD | 88.75% |
2020 FY | - CAD | -5.46% |
2020 Q4 | 188 Thousand CAD | 207.43% |
2020 Q1 | -1.93 Million CAD | -114.76% |
2020 Q2 | -1.55 Million CAD | 19.59% |
2019 Q3 | -3.97 Million CAD | 36.02% |
2019 Q1 | -6.2 Million CAD | 0.0% |
2019 Q2 | -6.2 Million CAD | -0.05% |
2019 FY | - CAD | 69.96% |
2019 Q4 | 13.11 Million CAD | 430.17% |
2018 Q1 | -14.52 Thousand CAD | 50.99% |
2018 FY | - CAD | -96181.35% |
2018 Q2 | -122.3 Thousand CAD | -742.26% |
2018 Q3 | -166.01 Thousand CAD | -35.74% |
2017 Q1 | -2216.00 CAD | 41.99% |
2017 FY | - CAD | 57.06% |
2017 Q4 | -29.62 Thousand CAD | -1876.38% |
2017 Q3 | -1499.00 CAD | 85.17% |
2017 Q2 | -10.1 Thousand CAD | -356.09% |
2016 Q3 | 4741.00 CAD | 161.91% |
2016 Q4 | -3820.00 CAD | -180.57% |
2016 FY | - CAD | 81.7% |
2016 Q1 | -2528.00 CAD | 70.27% |
2016 Q2 | -7658.00 CAD | -202.93% |
2015 Q1 | -38.85 Thousand CAD | 11.16% |
2015 FY | - CAD | 80.45% |
2015 Q3 | -7866.00 CAD | 98.09% |
2015 Q4 | -8502.00 CAD | -8.09% |
2015 Q2 | -411.48 Thousand CAD | -958.92% |
2014 Q2 | -266.24 Thousand CAD | -340.92% |
2014 Q3 | -55.39 Thousand CAD | 79.19% |
2014 Q1 | -60.38 Thousand CAD | -75.07% |
2014 Q4 | -43.73 Thousand CAD | 21.04% |
2014 FY | - CAD | -419.97% |
2013 Q4 | -34.49 Thousand CAD | -17.56% |
2013 FY | - CAD | -39.94% |
2013 Q2 | -22.7 Thousand CAD | 36.81% |
2013 Q3 | -29.33 Thousand CAD | -29.22% |
2013 Q1 | -35.93 Thousand CAD | 33.16% |
2012 Q3 | -30.36 Thousand CAD | 92.15% |
2012 Q1 | 529.57 Thousand CAD | 590.95% |
2012 FY | - CAD | 92.64% |
2012 Q4 | -53.75 Thousand CAD | -77.05% |
2012 Q2 | -386.79 Thousand CAD | -173.04% |
2011 FY | - CAD | -216.59% |
2011 Q4 | -107.86 Thousand CAD | -45.75% |
2011 Q3 | -74 Thousand CAD | -110.06% |
2011 Q2 | 735.48 Thousand CAD | -41.89% |
2011 Q1 | 1.26 Million CAD | 140.1% |
2010 Q4 | -3.15 Million CAD | -1262.23% |
2010 Q3 | -231.69 Thousand CAD | -117.29% |
2010 FY | - CAD | -82.3% |
2010 Q2 | 1.34 Million CAD | 3658.49% |
2010 Q1 | -37.66 Thousand CAD | 86.66% |
2009 Q3 | 173.2 Thousand CAD | -97.51% |
2009 FY | - CAD | 1187.53% |
2009 Q4 | -282.47 Thousand CAD | -263.09% |
2009 Q2 | 6.94 Million CAD | 3259.48% |
2009 Q1 | -219.77 Thousand CAD | -300.05% |
2008 FY | - CAD | 42.24% |
2008 Q1 | -172.72 Thousand CAD | -17.72% |
2008 Q2 | -200.03 Thousand CAD | -15.81% |
2008 Q3 | -9415.00 CAD | 95.29% |
2008 Q4 | -54.93 Thousand CAD | -483.51% |
2007 Q3 | -98.53 Thousand CAD | -2.28% |
2007 Q4 | -146.72 Thousand CAD | -48.91% |
2007 Q2 | -96.34 Thousand CAD | 54.24% |
2007 Q1 | -210.55 Thousand CAD | 69.72% |
2007 FY | - CAD | -960.79% |
2006 Q2 | -12.3 Thousand CAD | 94.45% |
2006 Q3 | -67.72 Thousand CAD | -450.22% |
2006 Q1 | -221.71 Thousand CAD | 38.42% |
2006 FY | - CAD | 74.22% |
2006 Q4 | -695.35 Thousand CAD | -926.72% |
2005 Q4 | -360.04 Thousand CAD | -527.15% |
2005 Q1 | -179.55 Thousand CAD | -19.23% |
2005 Q3 | -57.4 Thousand CAD | -100.78% |
2005 Q2 | -28.59 Thousand CAD | 84.08% |
2005 FY | - CAD | -173.86% |
2004 Q2 | -68.98 Thousand CAD | -146.59% |
2004 Q4 | -150.59 Thousand CAD | -362.46% |
2004 Q3 | -32.56 Thousand CAD | 52.79% |
2004 FY | - CAD | -81.47% |
2004 Q1 | -27.97 Thousand CAD | -38.99% |
2003 Q3 | -13.51 Thousand CAD | 27.88% |
2003 FY | - CAD | -18.67% |
2003 Q4 | -20.12 Thousand CAD | -48.9% |
2003 Q1 | -21.02 Thousand CAD | 22.74% |
2003 Q2 | -18.74 Thousand CAD | 10.83% |
2002 Q4 | -27.2 Thousand CAD | -131.19% |
2002 Q3 | -11.76 Thousand CAD | 4.42% |
2002 Q1 | -19.8 Thousand CAD | 7.28% |
2002 FY | - CAD | -25.07% |
2002 Q2 | -12.31 Thousand CAD | 37.83% |
2001 Q4 | -21.35 Thousand CAD | -27.1% |
2001 Q3 | -16.8 Thousand CAD | -139.83% |
2001 Q2 | -7007.00 CAD | -8.13% |
2001 Q1 | -6480.00 CAD | 0.0% |
2001 FY | - CAD | 22.33% |
2000 FY | - CAD | 20.4% |
2000 Q2 | -11.14 Thousand CAD | -70.13% |
2000 Q3 | -13.39 Thousand CAD | 4.36% |
2000 Q1 | -8229.00 CAD | 0.0% |
1999 FY | - CAD | -58.54% |
1999 Q3 | -15.79 Thousand CAD | 0.0% |
1998 FY | - CAD | 0.0% |
1998 Q3 | -15.96 Thousand CAD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Aequus Pharmaceuticals Inc. | -2.68 Million CAD | 311.794% |
CanadaBis Capital Inc. | 5.67 Million CAD | -0.019% |
Delivra Health Brands Inc. | 2.35 Million CAD | -141.249% |
Entourage Health Corp. | -21.39 Million CAD | 126.541% |
Lifeist Wellness Inc. | -12.76 Million CAD | 144.472% |
Cannara Biotech Inc. | 17.18 Million CAD | 66.958% |
Medicure Inc. | 1.27 Million CAD | -346.112% |
PharmaCielo Ltd. | -12.01 Million CAD | 147.252% |
Rubicon Organics Inc. | 1.94 Million CAD | -191.53% |
BioSyent Inc. | 9.05 Million CAD | 37.301% |
Voyageur Pharmaceuticals Ltd. | -1.22 Million CAD | 565.129% |